Accrol Group Holdings plc is a leading independent tissue converter, manufacturing toilet rolls, kitchen rolls, facial tissues and AFH products to supply retailers throughout the UK. Accrol imports parent reels from around the world and converts them into finished goods at the Company’s 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 17 million units per week and supplies some of the UK’s largest retailers.

Accrol Group Holdings plc is listed on AIM, the growth market of the London Stock Exchange.

The Company was incorporated and registered in England and Wales on 30 April 2014 under the Act with registered number 9019496 as a private company limited by shares with the name Aghoco 1220 Limited. The name of the Company was changed to Accrol Group Holdings Limited on 1 August 2014. The Company was re-registered as a public limited company with the name Accrol Group Holdings plc on 1st June 2016. Accrol Group Holdings plc’s main country of operation is the UK.

The Company, and the Group, trade under the name “Accrol Papers”.

Large buys today.

Large buys today.

Forecast Key Dates

Next AGM Confirmed 30/09/2016
Next year end (to be reported) 30/04/2017
Next prelim announcement Approximate 24/07/2017
Next annual report due Approximate 04/09/2017
Next interim announcement Approximate 25/12/2017

New high.:-))

And in my opinion with plenty more to go, can't call it but even at this level will be a multi-bagger.

Was hoping it would fall to stock up on more and if it does I most certainly will

All good for me glad I got in at the IPO should have got more then, but then isn't that always the way when you have a good one

Good to hear from you Stevesham. I'm up 16% now. :-)) This will move with the installation of the new machine/ machines and any announcements at the agm.

Hi Dreamcatcher love your posts, and yes this is a good solid one for pure growth I so need to buy more when prudent to do so

16% for me too, which if I am right is only the tip of the iceberg

I think if it drops below £1.20 I could be quite easily tempted to get more, however I really can only see this going one way and that is up!

Bought more today Stevesham, sitting on a good holding now.

Nice 300,000 @ 130p


http://www.moneyam.com/trades/ACRL

Excellent, and congratulations on your new purchase! I am so tempted for more.....

They will head towards 200p perhaps by the new year or early part of.

RNS Number : 2527L
Accrol Group Holdings PLC
29 September 2016
 
This announcement contains inside information
 
Accrol Group Holdings plc (the "Company" or "Accrol")
 
Director's Dealing
 
Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce that is has been notified that Stephen Crossley, CEO of Accrol, has purchased 100,000 ordinary shares of £0.001 each ("Ordinary Shares") via his SIPP on 29th September 2016 at a price of 132p per Ordinary Share.

Following this transaction, Stephen has an interest in 100,000 Ordinary Shares, representing approximately 0.1 per cent. of the Company's issued Ordinary Share capital.
 
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

A £132 grand spend by the CEO shows confidence. Lets hope for a good future.

AGM -NOTICE IS GIVEN that the Annual General Meeting of Accrol Group Holdings plc will be held at Stanley House Hotel, Mellor, Lancashire BB2 7NP on 30 September 2016 at 11am for the following purposes:

AGM notes

New high. :-))

Accrol general meeting. some good warehouse pictures


Next Event
30/04/2017
Next year end (to be reported)

Good large 25,000 and 100,000 buys. On the way now.


http://www.moneyam.com/trades/ACRL

Indeed well on the way and it's not going to drop to my target to buy more at £1.20, this I think will easily double.

Going to look at any dips (I doubt there will be any) and top up, better to average up than average down!

DYOR GLA :-)

ST of IC today - When a director splashes out over £100,000 buying shares in his company it’s always worth further investigation. I didn’t have to do much research in the case of Accrol (ARCL:140p), the Aim-traded Blackburn-based maker of toilet rolls, kitchen rolls and facial tissues, as this is a business I know well, having recommended buying the shares when they floated at 100p in the summer ('Clean up with Accrol', 6 Jun 2016), and subsequently reiterated that advice at 118p (‘Brexit winners’, 1 Aug 2016).
The fact that chief executive Stephen Crossley has just invested £132,000 of his own money buying 100,000 shares at a 32 per cent premium to the float price tells a story about Accrol’s trading prospects. Higher consumer demand for private-label products is helping drive ongoing strong sales growth from discount retailers, a segment where the company has a 35 per cent market share, as is management’s ability to cross sell multiple products to new clients. Maiden results have done nothing to alter my earlier positive stance: like-for-like sales rose by 17 per cent to £118m in the year to end April 2016, and analyst Mike Allen at house broker Zeus Capital expects Accrol to maintain this heady growth rate in the current financial year, pencilling in revenue of £138m.
On this basis, expect cash profits to rise by around 10 per cent to £16.4m to produce pre-tax profits of £13.4m and EPS of 11.5p in the 12 months to end April 2017. This means Accrol’s shares are being valued on a forward PE ratio of 12, a rating that fails to acknowledge its potential to continue to grow earnings at a double digit rate for years to come. Indeed, for the following year to end April 2018, Mr Allen believes that Accrol can lift revenues to £156m, increase both cash profits and pre-tax profits by £2.2m, and deliver EPS of 13.4p to reduce the forward PE ratio to 10.5. I am comfortable with those estimates.
The current rating also fails to fully reflect the company’s cash generation. Indeed, net debt is expected to fall to £16m by end April 2017, a sum equivalent to one times cash profits and less than 30 per cent of shareholders funds. So, with profits growing strongly, and the balance sheet modestly geared, the board can recycle cashflow into a progressive dividend. Guidance is for a 6p a share payout in the current year, implying the shares offer a 4.4 per cent prospective dividend yield, rising to around 6.25p a share the year after.
In the circumstances, it’s hardly surprising my 130p target price has proved too conservative and I now feel that a rating of 12 times EPS estimates of 13.4p for the 12 months to end April 2018 is a more realistic valuation. This implies a new target price of 160p, and one that more accurately takes into account Accrol’s low balance sheet gearing, and prospects of delivering double digit earnings growth. Buy.

Details of dividend below -



EVENT
TIMING
RECENT/UPCOMING DATES
Financial year
Year end 30 April
Half year end 31 October

Results published
Full year preliminary results
Our preliminary results for the year ending 30 April 2016 were released on 22 July 2016. These are available on the ‘Company Reports and Presentations’ page and in the ‘Regulatory News’ section of our website.

Interim results
Our interim results for the half year ending 31 October 2016 will be released mid-January 2017.
AGM
Late September
Our 2016 AGM was held on 30 September 2016 at 11am at Stanley House Hotel, Mellor. The AGM Result can be found on the ‘Regulatory News’ section of our website.
Dividends
Interim dividend record date November, paid January
An interim dividend of 1/3 is expected to be paid in January 2017.

Final dividend record date May, paid September (subject to shareholder approval).
A final dividend of 2/3 per share for the year ending 30 April 2017 is expected to be paid September 2017.